Will Maier, based in London, GB, is currently a Vice President, Rare Disease, Drug Development Sciences at ICON plc, bringing experience from previous roles at ICON plc (formerly Aptiv Solutions), Mapi Group, Bayer HealthCare and Takeda Pharmaceuticals. Will Maier holds a PhD in Epidemiology @ University of North Carolina at Chapel Hill. With a robust skill set that includes Pharmacovigilance, Outcomes Research, Epidemiology, Pharmaceutical Industry, Clinical Development and more, Will Maier contributes valuable insights to the industry. Will Maier has 3 emails on RocketReach.